ID   XP3CA
AC   CVCL_L769
SY   Xeroderma Pigmentosum 3 CAiro; GM02992; GM2292
DR   CLO; CLO_0012582
DR   BioSample; SAMN00808200
DR   Coriell; GM02992
DR   Wikidata; Q54837792
RX   CelloPub=CLPUB00447;
RX   PubMed=1383811;
RX   PubMed=7252263;
CC   Population: Egyptian.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
DI   NCIt; C114770; Xeroderma pigmentosum, complementation group C
DI   ORDO; Orphanet_910; Xeroderma pigmentosum
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   13Y
CA   Finite cell line
DT   Created: 06-05-13; Last updated: 29-06-23; Version: 15
//
RX   CelloPub=CLPUB00447;
RA   Mulivor R.A., Suchy S.F.;
RT   "1992/1993 catalog of cell lines. NIGMS human genetic mutant cell
RT   repository. 16th edition. October 1992.";
RL   (In) Institute for Medical Research (Camden, N.J.) NIH 92-2011; pp.1-918; National Institutes of Health; Bethesda (1992).
//
RX   PubMed=1383811; DOI=10.1016/0921-8777(92)90008-Q;
RA   Kantor G.J., Shanower G.A.;
RT   "A re-examination of the intragenome distribution of repaired sites in
RT   proliferating xeroderma pigmentosum complementation group C
RT   fibroblasts.";
RL   Mutat. Res. 293:55-64(1992).
//
RX   PubMed=7252263; DOI=10.1111/1523-1747.ep12479271;
RA   Cleaver J.E., Zelle B., Hashem N., El-Hefnawi M.H., German J.L. III;
RT   "Xeroderma pigmentosum patients from Egypt: II. Preliminary
RT   correlations of epidemiology, clinical symptoms and molecular
RT   biology.";
RL   J. Invest. Dermatol. 77:96-101(1981).
//